Wolff-Parkinson-White syndrome diagnosis overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:
* [[Delta waves]] are only present when the patient is in sinus rhythm, when[[ tachycardia]] starts the [[delta wave]] is no longer present.
* [[Delta waves]] are only present when the patient is in sinus rhythm, when[[ tachycardia]] starts the [[delta wave]] is no longer present.
* Patients [[WPW]] syndrome with episodes of [[atrial fibrillation]] will present [[ECG ]] with rapid irregular [[wide-complex tachycardia]].<ref name="Fengler-2007">{{Cite journal  | last1 = Fengler | first1 = BT. | last2 = Brady | first2 = WJ. | last3 = Plautz | first3 = CU. | title = Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED. | journal = Am J Emerg Med | volume = 25 | issue = 5 | pages = 576-83 | month = Jun | year = 2007 | doi = 10.1016/j.ajem.2006.10.017 | PMID = 17543664 }}</ref>   
* Patients [[WPW]] syndrome with episodes of [[atrial fibrillation]] will present [[ECG ]] with rapid irregular [[wide-complex tachycardia]].<ref name="Fengler-2007">{{Cite journal  | last1 = Fengler | first1 = BT. | last2 = Brady | first2 = WJ. | last3 = Plautz | first3 = CU. | title = Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED. | journal = Am J Emerg Med | volume = 25 | issue = 5 | pages = 576-83 | month = Jun | year = 2007 | doi = 10.1016/j.ajem.2006.10.017 | PMID = 17543664 }}</ref>   
* The combination of [[atrial fibrillation]] and [[WPW]]increase the risk of very rapid [[antidromic AVRT]] and occurrence of [[ventricular fibrillation]].
* The combination of [[atrial fibrillation]] and [[WPW]] may increase the risk of very rapid [[antidromic AVRT]] and occurrence of [[ventricular fibrillation]].
* [[AV node]] blocking agents are contraindicated in these patients because it will enhance the conduction through the [[accessory pathway]].
* [[AV node]] blocking agents are contraindicated in these patients because it will enhance the conduction through the [[accessory pathway]].
* Patients with [[WPW]] may exhibit more than one [[accessory pathway]] which is common in patientds with [[Ebstein's anomaly]].<ref name="europace.oxfordjournals.org">{{Cite web  | last =  | first =  | title = Radiofrequency ablation of multiple accessory pathways | url = http://europace.oxfordjournals.org/content/4/3/273 | publisher =  | date =  | accessdate = 14 April 2014 }}</ref>
* Patients with [[WPW]] may exhibit more than one [[accessory pathway]] which is common in patientds with [[Ebstein's anomaly]].<ref name="europace.oxfordjournals.org">{{Cite web  | last =  | first =  | title = Radiofrequency ablation of multiple accessory pathways | url = http://europace.oxfordjournals.org/content/4/3/273 | publisher =  | date =  | accessdate = 14 April 2014 }}</ref>

Revision as of 08:18, 14 September 2020

Wolff-Parkinson-White syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Wolff-Parkinson-White syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Approach

History and Symptoms

Electrocardiogram

EKG Examples

Other Diagnostic Studies

Treatment

Risk Stratification

Cardioversion

Medical Therapy

Catheter Ablation

Prophylaxis

Consensus Statement

Case Studies

Case #1

Wolff-Parkinson-White syndrome diagnosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wolff-Parkinson-White syndrome diagnosis overview

CDC onWolff-Parkinson-White syndrome diagnosis overview

Wolff-Parkinson-White syndrome diagnosis overview in the news

Blogs on Wolff-Parkinson-White syndrome diagnosis overview

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Wolff-Parkinson-White syndrome diagnosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]

Overview

References

  1. Sethi, KK.; Dhall, A.; Chadha, DS.; Garg, S.; Malani, SK.; Mathew, OP. (2007). "WPW and preexcitation syndromes". J Assoc Physicians India. 55 Suppl: 10–5. PMID 18368860. Unknown parameter |month= ignored (help)
  2. Fengler, BT.; Brady, WJ.; Plautz, CU. (2007). "Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED". Am J Emerg Med. 25 (5): 576–83. doi:10.1016/j.ajem.2006.10.017. PMID 17543664. Unknown parameter |month= ignored (help)
  3. "Radiofrequency ablation of multiple accessory pathways". Retrieved 14 April 2014.
  4. Nikoskelainen, EK.; Savontaus, ML.; Huoponen, K.; Antila, K.; Hartiala, J. (1994). "Pre-excitation syndrome in Leber's hereditary optic neuropathy". Lancet. 344 (8926): 857–8. PMID 7916404. Unknown parameter |month= ignored (help)
  5. Mashima Y, Kigasawa K, Hasegawa H, Tani M, Oguchi Y. (1996). "High incidence of pre-excitation syndrome in Japanese families with Leber's hereditary optic neuropathy" (subscription required). Clinical Genetics. 50 (6): 535–7. PMID 9147893.

Template:WH Template:WS